291 related articles for article (PubMed ID: 2241435)
21. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
Ruchlemer R; Yinnon AM; Hershko C
Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
[TBL] [Abstract][Full Text] [Related]
22. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
Karthaus M; Hentrich M
Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
[TBL] [Abstract][Full Text] [Related]
23. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for the treatment of established fungal infections.
Thursky KA; Playford EG; Seymour JF; Sorrell TC; Ellis DH; Guy SD; Gilroy N; Chu J; Shaw DR
Intern Med J; 2008 Jun; 38(6b):496-520. PubMed ID: 18588522
[TBL] [Abstract][Full Text] [Related]
25. [Fungal infections in leukemic patients: our experience during 5 years].
Torre MA; Escalante R; López Martín JC; de la Maya MD; Martínez Estéfano E; López Lacomba D; González Aza C
Sangre (Barc); 1996 Oct; 41(5):395-7. PubMed ID: 9026926
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology.
Maschmeyer G; Beinert T; Buchheidt D; Cornely OA; Einsele H; Heinz W; Heussel CP; Kahl C; Kiehl M; Lorenz J; Hof H; Mattiuzzi G
Eur J Cancer; 2009 Sep; 45(14):2462-72. PubMed ID: 19467584
[TBL] [Abstract][Full Text] [Related]
27. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
[TBL] [Abstract][Full Text] [Related]
28. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
30. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
31. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
Karthaus M; Böhme A
Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
[TBL] [Abstract][Full Text] [Related]
33. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
34. Prevention and treatment of invasive fungal diseases in neutropenic patients.
Almyroudis NG; Segal BH
Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
[TBL] [Abstract][Full Text] [Related]
35. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
36. Management of the febrile neutropenic patient with cancer.
Gucalp R
Oncology (Williston Park); 1991 Jul; 5(7):137-44, 147; discussion 148. PubMed ID: 1837473
[TBL] [Abstract][Full Text] [Related]
37. Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer.
Lin MT; Lu HC; Chen WL
Clin Infect Dis; 2001 Nov; 33(10):1621-7. PubMed ID: 11595977
[TBL] [Abstract][Full Text] [Related]
38. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
[TBL] [Abstract][Full Text] [Related]
39. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
[TBL] [Abstract][Full Text] [Related]
40. [Prophylaxis and treatment of invasive fungal infection in neutropenic patients].
Vallejo C; Rovira M
Rev Esp Quimioter; 2010 Dec; 23(4):177-83. PubMed ID: 21191555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]